Vici Health Sciences was founded by Dr. Anish Dhanarajan, PhD and Francesca Minale, M.Eng in 2016 with the aim of developing and commercializing high quality medicine at affordable prices to serve unmet patient needs. Vici’s goal is to become the go-to development partner for pharmaceutical companies seeking better product development outcomes. In pursuit of this goal, Vici has established a rapid prototyping R&D facility capable of GMP operations in Maryland USA.
Working with manufacturing and distribution partners, Vici has filed eight ANDA applications, seven of which have been approved. Vici is currently working on an exciting portfolio of diverse ANDA and 505(b)(2) products. Contact us for licensing and partnership opportunities!
What We Do
Scientific excellence, innovation and integrity are the three pillars upon which Vici is built. We offer our partners and clients a variety of development and manufacturing solutions for achieving rapid and sustained growth through introducing new products.
We are proven experts at developing ANDA and 505(b)(2) formulations, analytical methods and manufacturing processes. Leveraging internal and external resources, we perform or oversee all aspects of pharmaceutical product development. This includes product selection, product development, CMO selection and deal negotiation, tech transfer and regulatory filing. Talk to us about long-term partnership options to secure your company's growth.